BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37170089)

  • 21. Role of Radical Surgery Following Preoperative Chemoradiotherapy in Octogenarians With Rectal Cancer: A SEER Analysis.
    Lim YJ; Kong M
    Anticancer Res; 2024 Jan; 44(1):417-425. PubMed ID: 38159981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: a SEER-Medicare analysis.
    Eil R; Diggs BS; Wang SJ; Dolan JP; Hunter JG; Thomas CR
    Cancer; 2014 Feb; 120(4):492-8. PubMed ID: 24194477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of chemoradiotherapy versus radiotherapy alone in patients with intermediate-risk nasopharyngeal carcinoma: a population-based analysis.
    Xu YC; Chen KH; Liang ZG; Zhu XD
    Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1793-1802. PubMed ID: 36335249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute.
    Jing W; Guo H; Kong L; Zhang Y; Wang H; An C; Zhu H; Yu J
    Medicine (Baltimore); 2016 Dec; 95(50):e5630. PubMed ID: 27977606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
    Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].
    Wang XM; Wang L; Wang X; Chen JQ; Li C; Zhang WC; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Lu N; Han C; Pang QS; Wang P; Sun XC; Zhang KX; Li GF; Li L; Liu ML; Wang YD; Qiao XY; Zhu SC; Zhou ZM; Zhao YD; Xiao ZF
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):889-896. PubMed ID: 34407597
    [No Abstract]   [Full Text] [Related]  

  • 28. A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.
    Hwang JY; Chen HS; Hsu PK; Chao YK; Wang BY; Huang CS; Liu CC; Wu SC
    Ann Surg; 2016 Jul; 264(1):100-6. PubMed ID: 26649580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage selection for neoadjuvant radiotherapy in non-cervical esophageal cancer: A propensity score-matched study based on the SEER database.
    Ma K; Yang Y; Wang S; Yang X; Lu T; Xi J; Jiang W; Zhan C; Zhu Y; Wang Q
    Thorac Cancer; 2018 Sep; 9(9):1111-1120. PubMed ID: 29961955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity and Outcomes in Patients With and Without Esophageal Stents in Locally Advanced Esophageal Cancer.
    Francis SR; Orton A; Thorpe C; Stoddard G; Lloyd S; Anker CJ
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):884-894. PubMed ID: 28864404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of neoadjuvant chemoradiotherapy in clinical T2N0M0 esophageal cancer: A population-based cohort study.
    Goense L; Visser E; Haj Mohammad N; Mook S; Verhoeven RHA; Meijer GJ; van Rossum PSN; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2018 May; 44(5):620-625. PubMed ID: 29478739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local treatment improves survival in patients with stage IVB cervical cancer.
    Xu JY; Chen JN; Lei J; Hu M; Wu SG; Zhou J
    Gynecol Oncol; 2022 Jun; 165(3):538-545. PubMed ID: 35490033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
    Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy Improves the Survival of Patients With Metastatic Cervical Cancer: A Propensity-Matched Analysis of SEER Database.
    Huang K; Jia M; Li P; Han J; Zhang R; Li Q; Qiao Y; Xu T; Ruan P; Song Q; Li Y; Fu Z
    Int J Gynecol Cancer; 2018 Sep; 28(7):1360-1368. PubMed ID: 30036221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis.
    Qi WX; Chen C; Zhao S; Chen J
    Int J Clin Oncol; 2022 Feb; 27(2):340-347. PubMed ID: 34731352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Chen Q; Chen J; Huang Z; Zhao H; Cai J
    Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is salvage radiotherapy optimal to patients with occult cervical cancer undergoing inadvertent simple hysterectomy? A propensity score-matched analysis of a nationwide clinical oncology database.
    Wang Y; Ouyang Y; Su J; Xiao L; Bai Z; Cai Q; Cao X
    Jpn J Clin Oncol; 2021 Apr; 51(4):630-638. PubMed ID: 33395486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis.
    Ferrandina G; Gallotta V; Federico A; Fanfani F; Ercoli A; Chiantera V; Cosentino F; Turco LC; Legge F; Anchora LP; Bizzarri N; Moroni R; Macchia G; Valentini V; Scambia G
    Ann Surg Oncol; 2021 Jul; 28(7):3616-3626. PubMed ID: 33165720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.